SHW
NYSE · Chemicals
Sherwin-Williams Co/The
$321.95
+8.25 (+2.63%)
Financial Highlights (FY 2026)
Revenue
23.72B
Net Income
2.58B
Gross Margin
48.8%
Profit Margin
10.9%
Rev Growth
+2.1%
D/E Ratio
2.41
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 48.8% | 48.8% | 62.2% | 62.2% |
| Operating Margin | 14.2% | 12.8% | 16.3% | 16.3% |
| Profit Margin | 10.9% | 10.4% | 10.5% | 11.9% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 23.72B | 23.23B | 44.35B | 39.82B |
| Gross Profit | 11.59B | 11.35B | 27.60B | 24.78B |
| Operating Income | 3.38B | 2.98B | 7.22B | 6.51B |
| Net Income | 2.58B | 2.28B | 4.66B | 4.75B |
| Gross Margin | 48.8% | 48.8% | 62.2% | 62.2% |
| Operating Margin | 14.2% | 12.8% | 16.3% | 16.3% |
| Profit Margin | 10.9% | 10.4% | 10.5% | 11.9% |
| Rev Growth | +2.1% | +2.1% | +15.0% | +13.2% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 29.36B | 29.36B | 5.98B | 6.13B |
| Total Equity | 12.20B | 12.20B | 36.70B | 37.50B |
| D/E Ratio | 2.41 | 2.41 | 0.16 | 0.16 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 4.21B | 3.91B | 10.53B | 10.37B |
| Free Cash Flow | — | — | 3.77B | 4.33B |